Medicare Enrolled

Dr. Sepideh Kazemi, MD

Interventional Cardiology · Irvine, CA
Practice pattern: Remote & Cardiac — Practice combining remote and cardiac services
Low-engagement
16300 SAND CANYON AVE, Irvine, CA 92618
9494539393
In practice since 2006 (19 years)
NPI: 1518974583 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kazemi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kazemi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kazemi

Dr. Sepideh Kazemi is an interventional cardiology specialist in Irvine, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kazemi performed 7,525 Medicare services across 2,706 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kazemi received a total of $868 from 20 pharmaceutical and/or device companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kazemi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in CA $868 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,525
Medicare services
Top 14% in CA for interventional cardiology
2,706
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~396 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,943 $105 $291
Remote patient monitoring device, 30 days
Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period.
1,685 $45 $150
Remote patient monitoring management, 20 min/month
Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month.
1,446 $43 $120
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
595 $12 $55
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
423 $176 $753
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
348 $42 $228
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
292 $81 $304
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
146 $403 $1,100
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
146 $54 $230
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
112 $137 $440
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
48 $165 $480
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts
A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels.
40 $160 $450
Pacemaker programming, dual lead system
Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings.
38 $71 $130
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
37 $172 $481
Echocardiogram, transthoracic
An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers.
29 $46 $131
Echocardiogram with color Doppler
An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function.
29 $22 $60
Stress echocardiogram with ECG monitoring
An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings.
29 $210 $550
Continuous external EKG monitoring, 8-15 days
This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days.
27 $11 $60
External EKG monitoring, 8-15 days
Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm.
25 $22 $60
New patient office visit, complex (60-74 min) 22 $185 $550
Remote physiologic monitoring setup and education
Initial setup of remote monitoring equipment and patient education on its use.
19 $18 $50
Continuous EKG monitoring review, 48-7 days
Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days.
16 $20 $60
2-day continuous ECG with review and report
A two-day continuous electrocardiogram recording that includes a professional review and written report of the results.
15 $63 $277
Continuous external EKG monitoring, 48 hours to 7 days
This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days.
15 $11 $60
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.0% high complexity
14.3% medium
78.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$868
Total received (2018-2024)
Avg $124/year across 7 years
Bottom 20% in CA for interventional cardiology
20
Companies
37
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$736 (84.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (15.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$83
2023
$169
2022
$221
2021
$40
2020
$40
2019
$74
2018
$240

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$42
Esperion Therapeutics, Inc.
$23
AstraZeneca Pharmaceuticals LP
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$219
Novo Nordisk Inc
$122
AstraZeneca Pharmaceuticals LP
$76
Amgen Inc.
$72
Abbott Laboratories
$51
Janssen Pharmaceuticals, Inc
$49
Novartis Pharmaceuticals Corporation
$40
Kestra Medical Technology Services, Inc.
$32
Boston Scientific Corporation
$24
Esperion Therapeutics, Inc.
$23
Philips Electronics North America Corporation
$22
iRhythm Technologies, Inc.
$21
Venclose Inc.
$19
Merck Sharp & Dohme LLC
$18
HeartFlow, Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$15
Medtronic, Inc.
$14
PFIZER INC.
$12
Braemar Manufacturing, LLC
$12
Tactile Systems Technology Inc
$11
Top 3 companies account for 48.0% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ABILIFY · Assure WCD · BRILINTA · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · ELIQUIS · ENTRESTO · EVRSF · FARXIGA · FLEXITOUCH · GENERAL BRADY · LATITUDE · LEQVIO · MYCARELINK · NEXLETOL · Ozempic · Pacemakers · Repatha · VERQUVO · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an interventional cardiology specialist in Irvine?
Compare interventional cardiologists in the Irvine area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
45
Per 100K population
1.4
County median income
$113,702
Nearest hospital
HOAG ORTHOPEDIC INSTITUTE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kazemi is a remote & cardiac specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kazemi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kazemi performed 1,943 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kazemi receive payments from pharmaceutical companies?
Yes. Dr. Kazemi received a total of $868 from 20 companies across 37 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kazemi's costs compare to other interventional cardiologists in Irvine?
Dr. Kazemi's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kazemi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →